Literature DB >> 24631193

Intrahepatic bile duct regeneration in mice does not require Hnf6 or Notch signaling through Rbpj.

Teagan J Walter1, Charles Vanderpool2, Ashley E Cast3, Stacey S Huppert4.   

Abstract

The potential for intrahepatic bile duct (IHBD) regeneration in patients with bile duct insufficiency diseases is poorly understood. Notch signaling and Hnf6 have each been shown to be important for the morphogenesis of IHBDs in mice. One congenital pediatric liver disease characterized by reduced numbers of IHBDs, Alagille syndrome, is associated with mutations in Notch signaling components. Therefore, we investigated whether liver cell plasticity could contribute to IHBD regeneration in mice with disruptions in Notch signaling and Hnf6. We studied a mouse model of bile duct insufficiency with liver epithelial cell-specific deficiencies in Hnf6 and Rbpj, a mediator of canonical Notch signaling. Albumin-Cre Hnf6(flox/flox)Rbpj(flox/flox) mice initially developed no peripheral bile ducts. The evolving postnatal liver phenotype was analyzed using IHBD resin casting, immunostaining, and serum chemistry. With age, Albumin-Cre Hnf6(flox/flox)Rbpj(flox/flox) mice mounted a ductular reaction extending through the hepatic tissue and then regenerated communicating peripheral IHBD branches. Rbpj and Hnf6 were determined to remain absent from biliary epithelial cells constituting the ductular reaction and the regenerated peripheral IHBDs. We report the expression of Sox9, a marker of biliary epithelial cells, in cells expressing hepatocyte markers. Tissue analysis indicates that reactive ductules did not arise directly from preexisting hilar IHBDs. We conclude that liver cell plasticity is competent for regeneration of IHBDs independent of Notch signaling via Rbpj and Hnf6.
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24631193      PMCID: PMC4005980          DOI: 10.1016/j.ajpath.2014.01.030

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  DNA excision in liver by an albumin-Cre transgene occurs progressively with age.

Authors:  C Postic; M A Magnuson
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

2.  Bone marrow as a potential source of hepatic oval cells.

Authors:  B E Petersen; W C Bowen; K D Patrene; W M Mars; A K Sullivan; N Murase; S S Boggs; J S Greenberger; J P Goff
Journal:  Science       Date:  1999-05-14       Impact factor: 47.728

Review 3.  Progenitor cells in diseased human liver.

Authors:  Tania A Roskams; Louis Libbrecht; Valeer J Desmet
Journal:  Semin Liver Dis       Date:  2003-11       Impact factor: 6.115

4.  Mutations in the human Jagged1 gene are responsible for Alagille syndrome.

Authors:  T Oda; A G Elkahloun; B L Pike; K Okajima; I D Krantz; A Genin; D A Piccoli; P S Meltzer; N B Spinner; F S Collins; S C Chandrasekharappa
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

5.  Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury.

Authors:  George K Michalopoulos; Lindsay Barua; William C Bowen
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

6.  Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision.

Authors:  Hua Han; Kenji Tanigaki; Norio Yamamoto; Kazuki Kuroda; Momoko Yoshimoto; Tatsutoshi Nakahata; Koichi Ikuta; Tasuku Honjo
Journal:  Int Immunol       Date:  2002-06       Impact factor: 4.823

7.  Diminished hepatic expression of the HNF-6 transcription factor during bile duct obstruction.

Authors:  Ai-Xuan L Holterman; Yongjun Tan; Wooram Kim; Kyung W Yoo; Robert H Costa
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425

8.  Biochemical and immunological characterization of the DNA binding protein (RBP-J kappa) to mouse J kappa recombination signal sequence.

Authors:  Y Hamaguchi; Y Yamamoto; H Iwanari; S Maruyama; T Furukawa; N Matsunami; T Honjo
Journal:  J Biochem       Date:  1992-09       Impact factor: 3.387

9.  Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling.

Authors:  Luca Fabris; Massimiliano Cadamuro; Maria Guido; Carlo Spirli; Romina Fiorotto; Michele Colledan; Giuliano Torre; Daniele Alberti; Aurelio Sonzogni; Lajos Okolicsanyi; Mario Strazzabosco
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

10.  Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice.

Authors:  Romina Fiorotto; Aileen Raizner; Carola M Morell; Barbara Torsello; Roberto Scirpo; Luca Fabris; Carlo Spirli; Mario Strazzabosco
Journal:  J Hepatol       Date:  2013-03-07       Impact factor: 25.083

View more
  18 in total

Review 1.  Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.

Authors:  Luca Fabris; Romina Fiorotto; Carlo Spirli; Massimiliano Cadamuro; Valeria Mariotti; Maria J Perugorria; Jesus M Banales; Mario Strazzabosco
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08       Impact factor: 46.802

2.  Onecut transcription factors in development and disease.

Authors:  Peter A Kropp; Maureen Gannon
Journal:  Trends Dev Biol       Date:  2016

3.  Sox9 Is a Modifier of the Liver Disease Severity in a Mouse Model of Alagille Syndrome.

Authors:  Joshua M Adams; Kari A Huppert; Eumenia C Castro; Mario F Lopez; Nima Niknejad; Sanjay Subramanian; Neda Zarrin-Khameh; Milton J Finegold; Stacey S Huppert; Hamed Jafar-Nejad
Journal:  Hepatology       Date:  2020-01-24       Impact factor: 17.425

4.  Phylogenetic analyses of the hepatic architecture in vertebrates.

Authors:  Nobuyoshi Shiojiri; Harunobu Kametani; Noriaki Ota; Yusuke Akai; Tomokazu Fukuchi; Tomoka Abo; Sho Tanaka; Junri Sekiguchi; Sachie Matsubara; Hayato Kawakami
Journal:  J Anat       Date:  2017-12-04       Impact factor: 2.610

Review 5.  Molecular mechanisms of Sox transcription factors during the development of liver, bile duct, and pancreas.

Authors:  Chunyue Yin
Journal:  Semin Cell Dev Biol       Date:  2016-08-20       Impact factor: 7.727

Review 6.  Vascular patterning sets the stage for macro and micro hepatic architecture.

Authors:  Ashley E Cast; Teagan J Walter; Stacey S Huppert
Journal:  Dev Dyn       Date:  2014-11-18       Impact factor: 3.780

7.  Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1-/- mouse model of congenital hepatic fibrosis.

Authors:  Luca Fabris; Chiara Milani; Romina Fiorotto; Valeria Mariotti; Eleanna Kaffe; Barbara Seller; Aurelio Sonzogni; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  FASEB J       Date:  2022-06       Impact factor: 5.834

Review 8.  Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis.

Authors:  Changyu Zhu; Ira Tabas; Robert F Schwabe; Utpal B Pajvani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10-13       Impact factor: 46.802

9.  Transcription factor GATA6: a novel marker and putative inducer of ductal metaplasia in biliary atresia.

Authors:  Tea Soini; Marjut Pihlajoki; Noora Andersson; Jouko Lohi; Kari A Huppert; David A Rudnick; Stacey S Huppert; David B Wilson; Mikko P Pakarinen; Markku Heikinheimo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-02-01       Impact factor: 4.052

10.  Compensatory hepatic adaptation accompanies permanent absence of intrahepatic biliary network due to YAP1 loss in liver progenitors.

Authors:  Laura M Molina; Junjie Zhu; Qin Li; Tirthadipa Pradhan-Sundd; Yekaterina Krutsenko; Khaled Sayed; Nathaniel Jenkins; Ravi Vats; Bharat Bhushan; Sungjin Ko; Shikai Hu; Minakshi Poddar; Sucha Singh; Junyan Tao; Prithu Sundd; Aatur Singhi; Simon Watkins; Xiaochao Ma; Panayiotis V Benos; Andrew Feranchak; George Michalopoulos; Kari Nejak-Bowen; Alan Watson; Aaron Bell; Satdarshan P Monga
Journal:  Cell Rep       Date:  2021-07-06       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.